Statistics
Publications
17
Citations
832
H-Index
16
Active since
2007
Meichun Hu is an author at Hubei University of Science and Technology specializing in medicine, oncology, and pharmacology.
Publications per year
2007–2024
17
17
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Yundong He, Shihong Peng, Jinhua Wang et al. · Nature Communications · 2016 · 110 citations · Full text
Medicine, Oncology, Pharmacology +15
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
Qingxiang Lin, Yuan He, Xue Wang et al. · Advanced Science · 2020 · 82 citations · Full text
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
Meichun Hu, Shihong Peng, Yundong He et al. · Oncotarget · 2015 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
Jia Shen, Tao Zhang, Zheng Cheng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 61 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 17